Literature DB >> 14665962

Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury.

Arthur L Burnett1, Robyn E Becker.   

Abstract

PURPOSE: We investigated the long-term effect of immunophilin ligands on erection physiology and cavernous tissue histology using rat models of unilateral and bilateral cavernous nerve (CN) injury.
MATERIALS AND METHODS: Adult male Sprague-Dawley rats were administered the immunophilin ligand FK506 (5 mg/kg subcutaneously daily for 5 days), the nonimmunosuppressant FK506 derivative GPI1046 (3 to 3-pyridyl)-1-propyl(2 seconds)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylate) (40 mg/kg subcutaneously daily for 5 or 28 days) or saline immediately upon induction of 2 paradigms of cavernous nerve injury, namely focal transection of the CN unilaterally, and a combination of focal transection of the CN unilaterally and excision of a 5 mm segment of contralateral CN (BIL treated). At 28 days following CN injury electrical stimulation of the transected CN and penile erection monitoring were performed. Whole penes were removed and evaluated immunohistochemically for the nitric oxide generator neuronal nitric oxide synthase, the neuronal marker synaptophysin, the endothelial marker CD31 and the smooth muscle marker alpha-actin.
RESULTS: In unilaterally treated groups erection recovery was significantly greater in FK506 treated than in saline treated animals ((83.5% +/- 9.2% vs 24.3% +/- 8.1%, p <0.001) and similarly greater in GPI1046 treated animals than in the respective saline treated controls for this group (57.9% +/- 12.6% vs 23.8% +/- 7.0%, p <0.05). In BIL treated groups erection recovery for FK506 and GPI1046 treated rats exceeded saline treated values by approximately 70% (p <0.05) and 40% (p = 0.14), respectively. After 28 days of continuous treatment in BIL treated groups erection recovery for GPI1046 treated rats exceeded saline treated values by 140% (p <0.05). Neuronal and endothelial staining was preserved after immunophilin ligand treatment.
CONCLUSIONS: Immunophilin ligands exert neurotrophic effects on the penile innervation that preserve cavernous tissue structure and promote erectile function recovery in rats after extensive CN injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14665962     DOI: 10.1097/01.ju.0000089775.88825.ec

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

Review 1.  [Tissue engineering of erectile nerves].

Authors:  F May; N Weidner; K Matiasek; M Vroemen; T Mrva; C Caspers; J Henke; T Brill; A Lehmer; A Blesch; W Erhardt; B Gänsbacher; R Hartung
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

2.  Cavernous nerve stimulation and interposition grafting: a critical assessment and future perspectives.

Authors:  John P Mulhall
Journal:  Rev Urol       Date:  2005

3.  Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.

Authors:  Arthur L Burnett
Journal:  Rev Urol       Date:  2006

4.  GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunction.

Authors:  Arthur L Burnett; Sena F Sezen; Ahmet Hoke; Anthony O Caggiano; Jennifer Iaci; Gwen Lagoda; Biljana Musicki; Anthony J Bella
Journal:  J Sex Med       Date:  2015-01-30       Impact factor: 3.802

5.  Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats.

Authors:  Johanna L Hannan; Omer Kutlu; Bernard L Stopak; Xiaopu Liu; Fabio Castiglione; Petter Hedlund; Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Sex Med       Date:  2014-03-18       Impact factor: 3.802

6.  Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.

Authors:  Frank Edlich; Matthias Weiwad; Frank Erdmann; Jörg Fanghänel; Franziska Jarczowski; Jens-Ulrich Rahfeld; Gunter Fischer
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

7.  Cavernous Nerve Stimulation and Recording of Intracavernous Pressure in a Rat.

Authors:  Morten Hox; Travis Mann-Gow; Lars Lund; Peter Zvara
Journal:  J Vis Exp       Date:  2018-04-23       Impact factor: 1.355

8.  Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms.

Authors:  Heather Valentine; Yi Chen; Hongzhi Guo; Jocelyn McCormick; Yong Wu; Sena F Sezen; Ahmet Hoke; Arthur L Burnett; Joseph P Steiner
Journal:  Eur Urol       Date:  2006-11-16       Impact factor: 20.096

9.  Neuroregenerative strategies after radical prostatectomy.

Authors:  Robert C Dean; Tom F Lue
Journal:  Rev Urol       Date:  2005

Review 10.  Role of immunophilins in recovery of erectile function after cavernous nerve injury.

Authors:  Sena F Sezen; Gwen Lagoda; Arthur L Burnett
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.